share_log

Chardan Capital Maintains Buy on Ocugen, Maintains $6 Price Target

Benzinga ·  Nov 8 19:10  · Ratings

Chardan Capital analyst Daniil Gataulin maintains Ocugen (NASDAQ:OCGN) with a Buy and maintains $6 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment